This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M.-O.
Right arrow Articles by Lee, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M.-O.
Right arrow Articles by Lee, S. C.

 Previous Article  |  Next Article 

Journal of Virology, January 2006, p. 62-72, Vol. 80, No. 1
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.1.62-72.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Anti-CD45RO Suppresses Human Immunodeficiency Virus Type 1 Replication in Microglia: Role of Hck Tyrosine Kinase and Implications for AIDS Dementia

Mee-Ohk Kim,1,{dagger} Hyeon-Sook Suh,1 Qiusheng Si,1 Bruce I. Terman,1,2 and Sunhee C. Lee1*

Department of Pathology, Albert Einstein College of Medicine, Bronx, New York,1 Cardiology Division, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York2

Received 3 June 2005/ Accepted 30 September 2005

Macrophages and microglia are productively infected by HIV-1 and play a pivotal role in the pathogenesis of AIDS dementia. Although macrophages and microglia express CD45, a transmembrane protein tyrosine phosphatase, whether modulation of its activity affects human immunodeficiency virus type 1 (HIV-1) replication is unknown. Here, we report that of the five human CD45 isoforms, microglia express CD45RB and CD45RO (RB > RO) and treatment of microglia with a CD45 agonist antibody {alpha}CD45RO (UCHL-1) inhibits HIV-1 replication. {alpha}CD45RO prevented HIV-1 negative factor (Nef)-induced autophosphorylation of hematopoietic cell kinase (Hck), a myeloid lineage-specific Src kinase. Recombinant CD45 protein also inhibited HIV-1-induced Hck phosphorylation in microglia. Antennapedia-mediated delivery of Hck Src homology domain 3 (SH3), a domain that binds to the Nef PxxP motif with high affinity, reduced HIV-1-induced Hck phosphorylation and HIV-1 production in microglia. HIV-1-induced LTR transactivation was observed in U38 cells stably overexpressing wild-type Hck but not kinase-inactive Hck. In microglia, {alpha}CD45RO reduced activation of transcription factors (NF-{kappa}B and CCAAT enhancer binding protein) necessary for LTR transactivation in macrophages. These results establish that in myeloid lineage cells, Nef interacts with the Hck SH3 domain, resulting in autophosphorylation of Hck and an increase in HIV-1 transcription. {alpha}CD45RO-mediated inhibition of HIV-1 replication in microglia identifies the CD45 protein tyrosine phosphatase as a potential therapeutic target for HIV-1 infection/AIDS dementia.

* Corresponding author. Mailing address: Department of Pathology, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718) 430-2666. Fax: (718) 430-8867. E-mail: slee{at}aecom.yu.edu.

{dagger} Present address: Department of Neurology, Massachusetts General Hospital, Boston, MA 02114.

Journal of Virology, January 2006, p. 62-72, Vol. 80, No. 1
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.1.62-72.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»